Trehalose CAS NO 6138 23 4 is highly cost-effective, injection grade, product quality in line with ChP, USP, JP, EP standards, Registered in US FDA, DMF No.034401 and 035566).
NMPA CDE registration no.: F20200000284
USFDA DMF no.: 035566
| Product Name | D(+)-Trehalose dihydrate(For Injection)(Sterile) |
| Chemical Name | α-D-glucopyranosyl-α-D-glucopyranoside dihydrate |
| CAS No. | 6138-23-4 |
| NMPA CDE registration no. | F20190000452 |
| USFDA DMF No. | 034401 |
| Quality grade | injection |
| Quality standards | Conforms with USP, EP, JP, ChP standards |
| Molecular Formula | C12H22O11·2H2O |
| Applications and examples | Biological products, liposomes, vaccines, CAR-T, stem cells, diagnostic reagents, etc. |
| Product code | O08001 |
| Package sizes | 10kg |
| Storage condition | stored in a cool, dark, and dry place, and transported at room temperature |
FDA DMF NumberDMF: 35566；CDE Record registration Number: F20200000284.
Aseptic GMP production environment, low endotoxin (<2.5IU/g), injection grade.
Widely used in biological agents such as antibody drugs(e.g. Herceptin®).
AVT brand trehalose dihydrate (for injection) is commonly used as lyoprotectants.
Stabilizer and cryoprotectant for lipid nanoparticles and mRNA.
If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.
